Tumor necrosis factor receptor superfamily member 13B
분자 별명
CD267,TACI,TNFRSF13B
Drug Development Progress
임상 약물 수0
시판 약물 수0
최고 연구 개발 단계Preclinical
표적 별명
Transmembrane activator and CAML interactor,CD267,TACI
분자 배경
Transmembrane activator and CAML interactor (TACI), also known as tumor necrosis factor receptor superfamily member 13B (TNFRSF13B). It was originally discovered because of its ability to interact with calcium-modulator and cyclophilin ligand (CAML). TACI was later found to play a crucial role in humoral immunity by interacting with two members of the TNF family: BAFF and APRIL.
The present study demonstrated that, in NSCLC, a proliferation-inducing ligand (APRIL), B-cell maturation antigen (BCMA)and transmembrane activator and CAML interactor (TACI) proteins are abnormally expressed by immunohistochemistry, reverse transcription-quantitative polymerase chain reaction and western blotting. In addition, the expression of APRIL, BCMA and TACI were observed to be involved in extracellular signal-regulated kinase (ERK)1/2 activation in A549 cells.
TACI 제품 목록
No Data
You Have Viewed 0 Of 0 Results
1
No Data
No Data
Can’t find what you need?
Submit your requirements and our technical team will help.